Published in J Affect Disord on May 01, 2001
Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci (2005) 1.30
Meta-Review of Metanalytic Studies with Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depression. Clin Pract Epidemiol Ment Health (2011) 1.04
Repetitive Transcranial Magnetic Stimulation in the Treatment of depression: A Randomized, Double-blind, Placebo-controlled Trial. Indian J Psychol Med (2011) 0.97
"Getting physical": the management of neuropsychiatric disorders using novel physical treatments. Neuropsychiatr Dis Treat (2006) 0.92
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ont Health Technol Assess Ser (2016) 0.83
Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression - an open label trial. Neuropsychiatr Dis Treat (2007) 0.81
Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression. Neuropsychiatr Dis Treat (2013) 0.79
More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997-2013. Neuropsychiatr Dis Treat (2014) 0.79
Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study. BMC Psychiatry (2014) 0.78
Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.77
Short-term efficacy of repetitive transcranial magnetic stimulation (rTMS) in depression- reanalysis of data from meta-analyses up to 2010. BMC Psychol (2014) 0.77
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis. Prim Care Companion CNS Disord (2015) 0.75
Is there evidence for effectiveness of transcranial magnetic stimulation in the treatment of psychiatric disorders? Psychiatry (Edgmont) (2005) 0.75
Silent ischemia after neuroprotected percutaneous carotid stenting: a diffusion-weighted MRI study. AJNR Am J Neuroradiol (2006) 1.11
Depressive self-schemas, life stress, and vulnerability to depression. J Abnorm Psychol (1985) 1.04
Percutaneous transluminal angioplasty of the symptomatic atherosclerotic carotid arteries. Results, complications, and follow-up. Stroke (1996) 0.99
Initial symptom levels and the life-event-depression relationship. J Abnorm Psychol (1986) 0.98
Angioplasty and stenting for total symptomatic atherosclerotic occlusion of the subclavian or innominate arteries. Cerebrovasc Dis (2002) 0.94
Critical assessment of the current guidelines for the management and treatment of morbidly obese patients. J Endocrinol Invest (2007) 0.92
Endovascular stent-graft treatment of an iatrogenic vertebral arteriovenous fistula. Neuroradiology (2001) 0.89
Self-schemas and risk for depression: a prospective study. J Pers Soc Psychol (1985) 0.82
Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression. J Neurol Neurosurg Psychiatry (2001) 0.82
Tigecycline for treatment of nosocomial-acquired pneumonia possibly caused by multi-drug resistant strains of Stenotrophomonas maltophilia. J Chemother (2008) 0.81
Angioplasty of symptomatic high-grade internal carotid artery stenosis with intraluminal thrombus: therapeutic approach. Neuroradiology (2004) 0.79
Volume and composition of emboli in neuroprotected stenting of the carotid artery. AJNR Am J Neuroradiol (2008) 0.79
Internal carotid artery stenting in patients with near occlusion: 30-day and long-term outcome. AJNR Am J Neuroradiol (2010) 0.78
Depression and cognitive characteristics of stressful life-event types. J Abnorm Psychol (1982) 0.78
Degenerative ultrastructural changes observed in the neuropil of caudate nuclei from Parkinson's disease patients. Stereotact Funct Neurosurg (1990) 0.77
[Benzoyl peroxide in the treatment of decubitus ulcers]. Med Cutan Ibero Lat Am (1988) 0.75
[Coronary patients. The effect of diet and the population characteristics]. Rev Enferm (1994) 0.75
[Effect of phenoxybenzamine on certain lipid parameters of the serum in experimental hyperthyroidism in the rat]. Arch Farmacol Toxicol (1981) 0.75
[GESIDA/SEFH/PNS recommendations to improve adherence to antiretroviral therapy in 2004]. Farm Hosp (2004) 0.75
[TRH and lipid metabolism]. Arch Farmacol Toxicol (1978) 0.75
[Hyperperfusion syndrome as a complication of percutaneous transluminal angioplasty of the internal carotid artery]. Rev Neurol (2000) 0.75
[Effect of chlorisondamine on lipid determination parameters in experimental hyperthyroidism in the rat]. Arch Farmacol Toxicol (1982) 0.75
Multidisciplinary analysis of the effectiveness of autologous neural transplant (adrenal medulla) as treatment of Parkinson's disease. Stereotact Funct Neurosurg (1990) 0.75
[Left paracardial thymoma]. Rev Esp Cardiol (2001) 0.75
[Prevention of and attention to emergencies in South America]. Rev Sci Tech (1999) 0.75
[Influence of propranolol on the levels of total plasma fatty acids in experimental hyperthyroidism]. Arch Farmacol Toxicol (1979) 0.75
Dysfunctional cognitions and the effectiveness of skills and cognitive-behavioral assertion training. J Consult Clin Psychol (1980) 0.75